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INTRODUCTION 
Chronic kidney disease (CKD) is a gradual progressive irreversible 
loss of renal function over a period of months or years. About 10% of the 
global population may be affected by CKD. The rise in chronic kidney 
disease patients is primarily due to ageing population, diabetes, 
hypertension, glomerulonephropathy.  
CKD and its treatment Hemodialysis (HD) may lead to ocular 
complaints or exacerbation of underlying ocular disease like elevated 
Intraocular pressure (IOP), glaucoma, macular edema, age-related macular 
degeneration, ischemic optic neuropathy. 
 Glaucoma is a chronic progressive optic neuropathy caused by a 
group of ocular conditions which lead to damage of optic nerve with visual 
field defects. Increase in intraocular pressure which is the most common 
risk factor and an only treatable parameter of glaucoma. 
During hemodialysis changes in haemoconcentration, plasma 
colloid-osmotic pressure, plasma osmolarity during HD could be 
registrated. It is important to reveal their influence on ocular perfusion 
pressure and intraocular pressure.  
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Elevated intraocular pressure and decreased ocular perfusion 
pressure are the known risk factors for glaucoma development and 
progression. Unrecognised significant intraocular pressure elevation or 
ocular perfusion pressure reduction during hemodialysis could lead to 
glaucomatous optic nerve damage and subsequent irreversible visual loss. 
· Hemodialysis has been known to induce changes in the eye by an 
increase in IOP, when serum osmolality decreases during 
hemodialysis, the resulting imbalance in osmolality between the 
ocular chamber and the blood causes an influx of volume into the 
posterior chamber via the ciliary body.          
· Adequate oxygenation of ocular tissues depends on maintenance of 
ocular perfusion pressure through systemic regulation of blood 
pressure and local regulation of IOP, It has been proposed that 
vascular dysregulation leads to abnormal ocular perfusion and thus 
optic nerve ischemia, serving as an underlying cause of 
glaucomatous damage 
HD potentially produces only a transient change in OPP.  Low OPP 
is a risk factor for glaucoma development and progression when the 
abnormal ocular perfusion pressure is under issue, examining IOP and 
OPP changes occurring during individual HD sessions has been done and 
further investigated whether OPP levels reached thresholds associated with 
optic nerve damage. 
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NEED FOR STUDY 
Chronic kidney disease patients on Hemodialysis are found to have 
a transient increase in intraocular pressure and decrease in ocular perfusion 
pressure during hemodialysis. Hence it necessitates to monitor IOP & OPP 
for these patients as a routine during hemodialysis session and also during 
a routine examination of CKD patients who are on hemodialysis. This may 
help in early detection of elevation and fluctuation of IOP & OPP and also 
in early detection of glaucomatous optic nerve damage and subsequent 
irreversible visual loss. It also helps in early intervention in order to 
prevent the progression of the disease. 
This study was done among patients attending hemodialysis session 
in Nephrology Department, Govt. Stanley medical college & hospital, 
Chennai. 
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REVIEW OF LITERATURE 
Dr. Drance (1973) provided for the first time the definition of 
glaucoma as a disease of the optic nerve (an optic neuropathy) caused by 
numerous factors, called risk factors35. 
In 1826, William Bowman was recommending digital palpation as 
part of the routine examination of the eye. 
Von Graefe developed the first instrument for measuring 
intraocular pressure in 1865. 
The first applanation tonometer was introduced in 1867 by Adolph 
Weber but was not generally accepted. 
Imbert (1885) and Fick (1888) developed the principle on which 
modern applanation tonometers are based. 
Maklakoff applanation tonometer was the first reasonably accurate 
instrument for measuring the intraocular pressure of the late 19th century 
until relatively recently34. 
Schiötz developed an indentation tonometer that was widely used 
throughout the world during the first two-thirds of the 20th century 34.  
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Goldmann's applanation  tonometer  of  1950  began  the  era  of  truly  
accurate intraocular pressure measurement. 
Sitprija et al observed a significant increase in intra-ocular pressure 
in uraemic dogs, during hemodialysis.  
Watson & Greenwood' found a rise in intraocular pressure 
following hemodialysis in human beings. 
Los Angeles Latino Eye Study (LALES), a population-based study 
of over 6,000 adult Latinos, which recently reported a correlation between 
both high and low systemic blood pressures and the prevalence of OAG. 
The Baltimore Eye Survey found that those with DOPP <30 mmHg 
had a six-times higher risk of disease development than those with DOPP 
>50 mmHg. 
The Barbados Eye Study showed that individuals with the lowest 
20% of DOPP were 3.3-times more likely to develop glaucoma. In a 
subgroup of patients from the Barbados Eye Study followed for 9 years, 
lower OPPs and lower systolic BPs were again identified as risk factors. 
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AQUEOUS HUMOR INFLOW AND OUTFLOW –ANATOMY 
Aqueous inflow anatomy (i.e. site of aqueous formation) - Ciliary body 
Aqueous outflow pathway (i.e. drainage) anatomy located at the angle of 
anterior chamber 
AQUEOUS INFLOW ANATOMY: 
CILIARY BODY AND THE CILIARY PROCESSES: 
 The ciliary body is a part of the uveal tract. It is a triangular 
structure comprising of  
1. Ciliary body muscle 
2. Vessels 
3. Epithelia lining the ciliary processes 
4. Nerve terminals from the autonomic nervous system 
1. Ciliary body muscle: It is a non-striated muscle. It consists of two main 
portions: Longitudinal fibres & Circular fibres 
2. Ciliary processes: The functional unit responsible for aqueous humor 
secretion is the ciliary process. It is a whitish finger-like projection from 
the pars plicata part of the ciliary body 
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AQUEOUS INFLOW ANATOMY 
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AQUEOUS OUTFLOW PATHWAY – ANATOMY 
 Most of the aqueous drainage is through the anterior chamber angle. 
Anatomy: 
Aqueous outflow system includes: 
1. Trabecular meshwork  
i. Uveal meshwork 
ii. Juxtacanalicular (endothelial) meshwork 
iii. Corneoscleral meshwork 
2. Schlemm’s canal  
3. Collector channel 
4. Episcleral veins 
1. Trabecular meshwork: 
 The trabecular meshwork is a sieve-like structure bridging scleral 
sulcus  and  converts  it  into  a  tube  -  Schlemm’s  canal  .  It  consists  of  
endogenous glycosaminoglycan – hyaluronic acid, chondroitin, heparin, 
and dermatan and keratin sulphates2. The glycoproteins and GAG 
composition of the trabecular meshwork are not constant throughout life. 
Changes happen in composition as age advances, which have been 
implicated in the pathogenesis of primary open angle glaucoma. It consists 
of 3 portions  
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a) Uveal meshwork 
b) Corneoscleral meshwork 
c) Juxtacanalicular meshwork  
2. Schlemm’s canal: 
It is an oval channel embedded in the scleral sulcus. Its outer wall is 
lined by endothelial cells, which contains numerous openings of the 
collector channels. Torus or lip like thickening and septa are present to 
keep the canal open. 
3. Collector channels: 
The outer wall of schlemm’s canal has 25 to 35 opening for the 
collector channels. They connect the schlemm’s canal to the episcleral and 
conjunctival veins of the limbal region. 
4. Episcleral veins:   
 Most of the aqueous vessels drain into the episcleral veins, which 
ultimately drain into cavernous sinus via the anterior ciliary and superior 
ophthalmic veins. 
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AQUEOUS HUMOR INFLOW AND OUTFLOW –ANATOMY 
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AQUEOUS HUMOR 
 Aqueous humor is an intraocular fluid derived from the plasma 
within the capillary network of ciliary processes. The circulating aqueous 
humor enters the posterior chamber and flows around the lens and through 
the pupil into the anterior chamber. Within the anterior chamber, a 
temperature gradient (cooler toward the cornea) creates a convection flow 
pattern. 
Formation of aqueous humor:  
 The constituents of the aqueous humor traverse the three tissue 
layers  of  ciliary  processes;  the  capillary  wall,  the  stroma,  and  the  two  
layers of the epithelium. They undergo the following process as they pass 
through these layers. 
1. Diffusion :  
 It is a biophysical process. Lipid -soluble substances are 
transported through the lipid portions of the membrane proportional 
to a concentration gradient across the membrane (i.e.) Molecules 
of gas or solution distribute themselves uniformly throughout the 
space they are contained, by the motion of its particles. 
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2. Ultrafiltration 
 It is the transport of water and water soluble substance across the 
cell membrane through the protein micropores along the osmotic 
gradient and hydrostatic pressure   
3. Active Secretion:  
It is responsible for 90% of total aqueous production active transport 
of charged substances against the concentration gradient. This 
mechanism is believed to be mediated by globular proteins in the 
membrane. Energy is consumed in this process. The energy is 
derived by hydrolysis of adenosine triphosphate (ATP) 
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Composition of aqueous humor 
· 99.9% Water  
· Proteins concentration is 5-16mg/100ml 
· Glucose – 75% of the plasma concentration. 
· Electrolytes:  
o Sodium ion is similar in plasma and aqueous. 
o Bicarbonate ion Concentration is  increased in the posterior 
chamber. 
o chloride ion concentration is increased in aqueous than 
plasma and phosphate concentration is decreased than plasma. 
· Ascorbic acid concentration is very high in aqueous than plasma.  
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INTRAOCULAR PRESSURE 
 Intraocular pressure (IOP) is determined by the balance between the 
rate of aqueous production and its outflow. In individuals who are 
susceptible to glaucoma, “normal” intraocular pressure (IOP) may be 
defined as that pressure which does not lead to glaucomatous damage of 
the optic nerve head. The average IOP in the general population is around 
a range of about 11-21mmHg- two standard deviations either side of 
average 16 mmHg. 
FACTORS INFLUENCING INTRAOCULAR PRESSURE: 
1. Heredity: 
 Relatives of patients with POAG, tend to have increased IOP. 
2. Age: 
· Increase in IOP with age.  
· Related to reduced facility of aqueous outflow and uveoscleral 
outflow because aqueous production also decreases with increasing age. 
3. Gender: 
· IOP is equal between the sexes in the age group 20-40 years.  
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· In older age- apparent increase in mean IOP with age is higher in 
women and coincides with the onset of menopause. 
4. Ethnicity: 
· In the United States, blacks have higher IOPs than whites1. Recent 
studies using regression analysis of multiple covariates found that black 
race is not an independent risk factor  
· Full blood Indians in New Mexican tribe – found to have slight 
lower mean IOP 
5. Refractive error: 
· Myopes tend to have slight higher IOP 
6. Arterial blood pressure: 
IOP is generally not affected by physiological changes in arterial 
blood pressure; however, sudden large swings may affect the IOP 
accordingly. 
7. Systemic venous pressure (SVP): 
 Changes in SVP can cause a profound effect on IOP by affecting 
ipsilateral venous pressure, for about 1 mmHg rise in episcleral venous 
pressure raises the IOP by 0.8 mmHg. 
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8. Plasma osmolarity: 
 It affects the IOP profoundly. When the concentration of solutes in 
plasma is lower than the ocular fluids, the water will enter the eye from 
plasma and raise the IOP. This forms the basis of water drinking test used 
as a provocative test for glaucoma. 
When the total concentration of the solute molecule in the blood 
exceeds, the water from the eye (vitreous & aqueous) is withdrawn, 
lowering the IOP. This effect is used clinically to lower the IOP by use of 
hyperosmotic agents like mannitol. 
9. Blood pH: 
Systemic acidosis lowers the IOP. Metabolic acidosis induced by 
carbonic anhydrase inhibition that is responsible for their pressure 
lowering effect. 
10. Seasonal variation: 
 IOP has been recorded as highest during winter and lowest during 
summer. 
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11. Diurnal variation in IOP: 
 The IOP is subject to cyclic fluctuations throughout the day. The 
IOP was highest during the early morning and lowest in the late evening. 
A diurnal variation in IOP of more than 8mmHg is considered 
pathognomic. The physiologic mechanisms that regulate diurnal IOP 
variation are complex. The IOP is regulated in part by adrenocortical 
steroids and catecholamines. 
12. Postural Variation: 
 Postural variation in IOP showed the consistent elevation of IOP at 
night time. It is physiologically relevant because sleep occurs in the supine 
position. 
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TONOMETRY 
Measurement of IOP is known as tonometry. 
CLASSIFICATION OF TONOMETERS: 
 All clinical tonometers measure the IOP by relating a deformation of 
the globe to the force responsible for the deformation. The basic types of 
tonometers differ according to the shape of the deformation. 
1. Indentation.  
2. Applanation (flattening). 
3. Rebound tonometry  
Schiotz tonometer: 
 Schiotz developed the first device that quantified intraocular 
pressure. It’s based on the principles of indentation tonometry.  
Principle  
 Indentation tonometry measures amount of deformation of the 
anterior surface of the cornea by a fixed amount of force. The weight  of  
tonometer on the eye increases the actual IOP (Po) to a higher level (Pt). 
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The change in pressure from Po to Pt is an expression of the resistance of 
the eye (scleral rigidity) to the displacement of fluid. 
IOP  with  Tonometer  in  position  (Pt)  =Actual  IOP  (Po)  +  Scleral  
Rigidity (E) 
 Determination of Po from a scale reading, Pt requires conversion 
which is done according to Friedenwald conversion tables. Friedenwald 
generated a formula for the linear relationship between the log function of 
IOP and the ocular distension. 
                                    Pt = log Po + C ΔV 
C a numerical constant, coefficient of ocular rigidity= 0.025 
ΔV is the change in volume 
Technique: 
Explain the patient about the procedure and ask him to lie supine, 
fixing in primary position. Topical anaesthetic drops are instilled in the 
eyes. The foot plate of tonometer is kept on the cornea and the reading on 
the scale is read. It is then correlated with the Friedenwald conversion 
table provided with a tonometer. 
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SCHIOTZ TONOMETER 
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Goldmann Applanation Tonometer: 
 Goldmann applanation tonometer consists of a bi-prism mounted on 
a standard slit lamp. The prism applanates the cornea in an area of 3.06mm 
diameter. It is the most accurate tonometer. 
Principle: 
 The principle is based on IMBERT- FICK LAW. The pressure (P) 
within a sphere is roughly equal to the external force (F) needed to flatten 
a portion of the sphere divided by the area (A) of the sphere that is 
flattened. 
P = F/A 
Technique:  
Local anaesthetic is administered. Fluorescein dye impregnated 
paper (0.25%) is administered into the lower fornix. The two semicircles 
are viewed through the slit lamp under cobalt blue light at 60⁰.The 
fluorescein stained tear meniscus  facilitates visualisation at the margin of 
the contact between cornea and bi-prism. A central blue circle, which is 
the flattened cornea, surrounded by 2 yellow semi-circles which are the 
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tear meniscus is seen. Force against the cornea is adjusted until the inner 
edges overlap by turning measuring dial. 
Potential Errors:  
Overestimated readings  
1. Wide tear meniscus  
2. Unsatisfactory vertical alignment of vertical semicircles  
3. Thick cornea due to increased collagen content of stroma 
4. Increased corneal curvature 
5. Against the rule astigmatism  
Underestimated readings 
1. Measurement without use of fluorescein 
2. Inadequate fluorescein concentration 
3. Decreased corneal curvature 
4. With the rule astigmatism  
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GOLDMANN APPLANATION TONOMETER 
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Other tonometer types: 
1. Perkins applanation tonometer  
2. MacKay Marg tonometer  
3. Tono-Pen tonometer 
4. Pneumatic tonometer  
5. Non-contact airpuff tonometer 
6. Optical response analyser 
7. Dynamic contact tonometer (pascal) 
8. Rebound tonometer 
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OCULAR PERFUSION PRESSURE 
Ocular blood flow refers to the distribution of oxygenated blood 
throughout the ocular vasculature.  
Ocular perfusion pressure (OPP) is defined as the difference 
between arterial blood pressure and intraocular pressure. It refers to the 
pressure available to drive blood through the intraocular vasculature, and 
the amount of perfusion being influenced by the resistance to flow, which 
is a function of the vessel tone or the vessel calibre. This can be further 
described as systolic perfusion pressure and diastolic perfusion pressure. 
The following formulas are used to calculate36  
· Mean arterial pressure (MAP) 
             MAP= diastolic BP + 1/3(systolic BP-diastolic BP) 
· Ocular perfusion pressure (OPP) 
· OPP                    =  MAP-IOP 
· Systolic  SOPP  =  systolic BP- IOP 
· Diastolic DOPP =  diastolic BP- IOP 
· Mean  MOPP     =  2/3(MAP- IOP) 
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Ocular blood flow exhibits autoregulation, which is characterised by 
local vascular constriction or dilatation causing an increase or decrease in 
vascular resistance, thereby maintaining a constant nutrient supply in 
response to perfusion pressure changes. Ocular perfusion pressure is 
directly proportional to ocular blood flow  
o Ocular blood flow =  ocular perfusion pressure  
        Vascular resistance  
Ocular blood flow and ischemic injury to the optic nerve head is 
dependent on ocular perfusion pressure and vascular resistance. Any 
changes in ocular perfusion pressure ((i.e.) fluctuation in IOP or blood 
pressure) or vascular resistance (i.e. autoregulatory dysfunction) affect 
ocular blood flow.  
Lower ocular perfusion pressure is associated with an increased risk 
of the development of open-angle glaucoma as well as its progression. 
Several major studies, including the Baltimore Eye Survey, the Barbados 
Eye Study, the Egna-Neumarkt Study, and Projecto Ver, all studies 
identified low OPP as a risk factor for developing glaucoma. “In the 
Baltimore Eye Survey, glaucoma was six-fold more common in eyes with 
low versus high diastolic perfusion pressure.” 
According to the data from the on-going Los Angeles Latino Eye 
Study  (LALES),  this  is  evaluating  the  relationship  between  OPP  and  the  
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risk of having open-angle glaucoma. This is a cross-sectional, population-
based study of 6,130 adult Latinos in Los Angeles. All subjects underwent 
a comprehensive eye examination as well as blood pressure measurement. 
Overall, 1,770 subjects had systemic hypertension. It has been found that 
low systolic, diastolic, and mean OPP all led to increased risk of having 
open-angle glaucoma. Of these, the relationship between glaucoma risk 
and diastolic perfusion pressure was the strongest. The risk of glaucoma 
increases significantly as diastolic perfusion pressure falls. 
In the LALES data, it has also been reported that high systemic 
blood pressure was also related to an increased risk of glaucoma. It’s 
possible for both systemic hypertension and systemic hypotension to 
contribute to the risk of open-angle glaucoma. This is due to disruption of 
autoregulation of blood flow. 
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GLAUCOMA 
The word glaucoma  meant  ‘clouded ’  in  Greek.  Glaucoma  is  the  
second leading cause of blindness worldwide, with more than 50 million 
people affected. Glaucoma is a multifactorial disease and its precise 
pathogenesis, despite extensive research, remains unknown. 
The  term  does  not  refer  to  a  single  disease  entity,  but  rather  to  a  
group of diseases share certain features. It is characterised as a 
multifactorial optic neuropathy with a characteristic acquired atrophy of 
the optic nerve and loss of retinal ganglion cells and their axons, and 
manifesting characteristic visual field abnormalities.  
Intraocular pressure (IOP) is considered the main risk factor for the 
development and progression of glaucoma. At present, decreasing IOP is 
the only proven means halting the development and/or progression OAG 
Other risk factors for developing the disease  
OCULAR RISK FACTORS QUALITY OF EVIDENCE 
1. Intraocular pressure Excellent – Most Important 
2. Thinner central corneal thickness Excellent 
3. Myopia Excellent 
4. Disc haemorrhage Good 
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5.Increased cup/disc ratio Equivocal 
6.Asymmetric cupping Equivocal 
 
NON OCULAR RISK FACTORS QUALITY OF EVIDENCE 
1. Age Excellent  
2. Race (e.g. African or Hispanic descent) Excellent 
3. Family History Excellent 
4. Adult onset diabetes Equivocal 
5.Diastolic perfusion pressure Excellent 
6.Migraine and peripheral vasospasm Equivocal 
 
 There is increasing evidence that the cardiovascular system (e.g., 
altered blood flow) may play a major role in the pathogenesis OAG. The 
major cause of this reduction in ocular blood flow is thought to be 
secondary to vascular dysregulation in susceptible patients, resulting from 
abnormal/insufficient autoregulation. 
CLINICAL STAGING OF GLAUCOMA:  
1. Glaucoma suspects (at risk) 
o Optic disc asymmetry 
o Large physiological cup 
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o Low intraocular pressure in early to mid-twenties 
o Pigment dispersion syndrome 
o Positive family history of visual loss from glaucoma 
o Myopia  
o Hypermetropia  
o Presence of a gene known to be associated with glaucoma 
2. Pre glaucoma  
o IOP above 30mmHg 
o Abnormal disc appearance 
o Narrow occludable anterior chamber angle  
o Abnormal visual field without evidence of definite ocular 
damage  
3. Glaucoma  
o Asymptomatic glaucoma 
o Definite glaucoma damage but without symptoms  
o Symptomatic glaucoma 
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Pathogenesis of neuronal damage in glaucoma  
 Progressive optic neuropathy results from the death of retinal 
ganglion cells in a typical pattern which results in characteristic optic disc 
changes and visual field defects.  
A) Primary insults  
1. Mechanical theory  
· Elevated IOP led to direct compression and death of the neurons. 
· The entrance of optic nerve is the weakest part of eyeball increase in 
IOP this part pushed out first.  
· Increase in intraocular pressure à backward bowing of lamina 
cribrosa à axonal deformation àaxonal transport both orthograde 
and retrograde flow interrupted by compression & also leads to 
ischemia by altering capillary blood flow à neurotropin deprivation 
à lead to apoptosis of retinal ganglion cells.  
2. Vascular insufficiency theory ( Pressure independent factors): 
Factors affecting vascular perfusion pressure of optic nerve head are 
also implicated in glaucomatous optic neuropathy which includes 
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· Defective autoregulatory mechanism of blood flow 
· Systemic hypotension - nocturnal hypotension , patients on anti-
hypertensive medications  
· Vasospasm  
B) Secondary insults (excitotoxicity theory): 
· Retinal ganglion cell apoptosis due to glutamate-mediated toxicity  
· Glutamate is excitatory neurotransmitter à under hypoxic or 
ischemic conditions à glutamate accumulates and reaches toxicity 
concentration in the inter-synaptic junction. 
 
 
 
 
 
 
 
34 
 
GLAUCOMATOUS OPTIC DISC CHANGES: 
A. Definitely pathogenic signs 
o Documented diffuse thinning of neuroretinal rim 
o Acquired pit of optic nerve (pseudo pit) 
o Concentric enlargement of cup 
B. Highly suggestive signs  
o Asymmetric cup between eyes >0.2 
o Vertical extension of cup 
o Notching focal loss of neuroretinal rim 
o Localized haemorrhage crossing the disc 
o Bayoneting sign  
C. Moderate to mildly suggestive signs  
o CD ratio >0.6 
o Localized pallor of optic disc 
o Baring of circumlinear vessels  
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o Progressive vascular loops on the optic disc  
o Narrowing of retinal vessels  
o Dilated retinal veins  
o Peripapillary area beta zone atrophy  
D. Nonspecific signs  
o Nasal shift of disc vessels  
o Alteration of lamina cribrosa 
VISUAL FIELD LOSS IN GLAUCOMA  
Early defects: 
o Generalized depression  
o Nasal step or depression  
o Temporal wedge or depression  
o Enlargement and baring of blind spot  
o Isolated paracentral scotoma  
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Late defects:  
o Arcuate defects  
o Annular scotoma  
o end-stage field, with a small central island and a larger temporal 
crescent remaining. 
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ROLE OF OCULAR PERFUSION PRESSURE IN 
GLAUCOMA 
It is well established that the main risk factor for glaucoma is 
elevated intraocular pressure (IOP). Reducing IOP is effective in slowing 
down the progression of the disease but some patients still progress despite 
adequately controlled IOP. 
Besides the mechanical effect of raised intraocular pressure (IOP) 
on optic nerve head (ONH), several vascular risk factors such as systemic 
hypertension, atherosclerosis, vasospasm etc., have also been implicated as 
potential factors capable of increasing the risk of open-angle glaucoma 
(OAG). 
 The vascular hypothesis of OAG states that a low blood pressure 
(BP) relative to IOP can lead to low mean ocular perfusion pressure 
(MOPP), thus impairing perfusion of the ONH with resultant 
glaucomatous cupping and visual field loss. 
Several studies implicated vascular risk factors in the pathogenesis 
of glaucoma. Blood pressure (BP) and ocular perfusion pressure (OPP) 
being the most studied. This vascular hypothesis is based on abnormal 
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perfusion and the subsequent ischemia of the ONH play a major role in the 
glaucomatous damage.  
It has been reported that Low DBP, low MOPP and low DOPP were 
independent risk factors for OAG14.  Of  which  Low  DOPP  has  the  
strongest correlation with the development of glaucoma. The Baltimore 
Eye Survey found that those with DOPP <30 mmHg had a six-times higher 
risk  of  disease  development  than  those  with  DOPP  >50  mmHg38 . The 
Egna-Neumarkt Study reported a 4.5% increase in glaucoma prevalence in 
patients with DOPPs <50 mmHg compared with patients with DOPPs ≥66 
mmHg. According to Leske MC et al study, low mean ocular perfusion 
pressure (<42 mmHg), systolic perfusion pressure (<101 mmHg) and 
DOPP (<55 mmHg) were all shown to be risk factors for the development 
of glaucoma, with relative risks of 3.1, 2.6 and 3.2, respectively. 
Baseline for OPP37: 
o Systolic   OPP  (SOPP) less than  101 mm Hg 
o Diastolic OPP  (DOPP) less than  55 mm Hg 
o Mean      OPP  (MOPP) less than 42 mm Hg  
More likely to have open angle glaucoma.  
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Pathogenesis of Ocular Perfusion Pressure and Glaucoma:  
Impaired autoregulation: 
 Blood flow to many organs and tissue beds is autoregulated. The 
goal of autoregulation is to maintain a relatively constant blood flow, 
capillary pressure, and nutrient supply in spite of changes in perfusion 
pressure. Vascular bed in the ONH and retina maintains autoregulatory 
capacity over a wide range of perfusion pressures. 
 Autoregulation  of  blood  flow  is  due  to  alteration  in  resistance  to  
blood flow in the terminal arterioles, i.e. they dilate to increase the blood 
flow when the perfusion pressure falls, and constrict to reduce the blood 
flow in arterial hypertension. 
In an autoregulated vascular bed, changes in perfusion pressure do 
not translate into a change in blood flow, as long as the perfusion pressure 
is modified within the autoregulation range. However, in a non-
autoregulated vascular bed, small changes in perfusion pressure may lead 
to changes in blood flow. 
Breakdown of blood flow autoregulation in the ONH:  
Many systemic and local factors can cause this. The systemic causes 
include aging, arterial hypertension, diabetes mellitus, marked arterial 
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hypotension from any cause, arteriosclerosis, atherosclerosis, 
hypercholesterolemia, vasospasm and probably regional vascular 
endothelial disorders 30-33. It  is  also  possible  that  many  other,  as  yet  
unknown, causes can derange the autoregulation. And also some persons 
are born with defective autoregulation, for instance, those who suffer from 
Orthostatic arterial hypotension for no apparent reason. 
According to Liang et al. (2009) when OPP is challenged beyond 
the autoregulatory range, reduction of ocular blood flow occurs (ONH 
blood flow measured with laser speckle phenomenon13). 
· When IOP was increased and mean BP was normal, no significant 
change was observed in ONH blood flow, indicating that 
autoregulation was adequate. 
· When IOP was increased and mean arterial blood pressure was 
reduced down to 56 mmHg, significant reductions in ONH blood 
flow were observed. 
Suggesting that autoregulation was unable to maintain blood flow at 
extremely low OPP.   
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Vascular dysregulation is hypothesized to be involved in at least 
some Cases of glaucoma, especially in normal tension glaucoma and could 
lead not only to chronically low perfusion but too unstable perfusion with 
wide fluctuations. 
Vascular Endothelial Vasoactive Agents: 
 Vascular Endothelial Vasoactive Agents (vasoconstrictor & 
vasodilator) are formed by vascular endothelium. They play an important 
role in modulating the local vascular tone and most probably also in blood 
flow autoregulation. Production of these agents is impaired in many 
systemic and local conditions, and that would secondarily interfere with 
the ONH circulation. 
Fluctuation of BP and OPP: 
 Some studies have indicated that glaucoma patients show abnormal 
autoregulation especially in response to acute changes in OPP (Evans et al. 
1999; Galambos et al. 2006; Feke & Palquale 2008; Portmann et al. 2011). 
 Any increase in IOP or reduction in blood pressure may reduce the 
perfusion pressure of intraocular beds, which represents a challenge to the 
ocular circulation.  
43 
 
Nagel et al. (2001) compared the reaction of retinal vessels to a 
short-term increase of IOP to supra-systolic values by the suction cup 
method, using a retinal Vessel analyser (RVA). A short-term rise in IOP 
leads to a reduced retinal vessel reaction (change in vessel diameter) in 
POAG patients and that this might represent an impaired autoregulation. 
Circadian Variations in Ocular Perfusion Pressure 
 The term circadian rhythm was introduced in 1959 by Halberg16. It 
is defined as a biological cycle with a period of approximately 24 hr, 
representing an important biological regulator in every organism. 
Among various circulatory circadian responses in humans, the most 
prominent is the blood pressure dip at night during sleep, due to a decrease 
in  sympathetic  output.  IOP  has  also  been  shown  to  follow  a  pattern  of  
circadian change. IOP and BP are the determining variables show 
circadian change.  
It has been reported that during sleep, a reduction in both ocular 
perfusion pressure (OPP) and ocular blood flow may occur due to the 
combined effects of a rise in IOP and a dip of systemic BP (Trew & Smith 
1991a,b; Perlman et al. 2007). 
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Low nocturnal OPP might result in further damage in glaucoma 
patients, especially when autoregulation is impaired (Okuno et al. 2004). 
It has also been found that both anatomical (retinal nerve fibre layer 
thickness) and functional (visual field) outcome variables were 
significantly worse in glaucoma patients with wider circadian OPP 
fluctuation. 
 Choi et al. (2007) identified circadian OPP fluctuation as the most 
consistent clinical risk factor for glaucoma severity  
The Evidence - Epidemiologic Studies Linking Diastolic Perfusion 
Pressure and Glaucoma 8-12 
S.NO STUDY DESIGN 
Glaucoma Risk 
From Low DOPP 
vs. Normal DOPP 
1. Baltimore Eye Survey Cross-sectional 6-fold 
2. Egna-Neumarkt Study Cross-sectional 2.5-fold 
3. Proyecto VER Cross- sectional 4-fold 
4. Los Angeles Latino Eye 
Study 
Cross-sectional 1.9-fold 
5. Barbados Eye Study Longitudinal 3.2-fold (4 years) 
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Patient Subgroups- To Consider the Value of Assessing Ocular 
Perfusion Pressure: 
•  Normal-tension glaucoma 
•  Eyes with optic disc haemorrhage 
•  Patients with progression at low IOP 
•  History of low BP, multiple systemic antihypertensives, symptoms 
 of orthostasis 
•  Patients with nocturnal hypotension  
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EFFECT OF INTRAOCULAR PRESSURE ON 
HEMODIALYSIS 
Intraocular pressure (IOP) is a major risk factor for development and 
progression of the glaucomatous disease, and transient increases in IOP 
have been reported during HD in patients with and without glaucoma. 
Systemic variables that may affect IOP are changes in blood 
volume, plasma osmolarity, and colloidal osmotic pressure. Hemodialysis 
affects all of these parameters, and given the significant number of patients 
on dialysis, this could be an important factor in IOP control. 
Mechanism  
1. Rapid reduction in total serum osmolarity25-28 
· Most aqueous is produced by active transport mechanisms. 
· The ultrafiltration component of aqueous production is significant.  
It is this component that is affected by dialysis 
Urea has established an osmotic ocular gradient. During the dialytic 
process, solutes urea toxins, in particular, are removed from the blood. 
Delayed transport of urea across blood-aqueous barrier has been 
demonstrated. Rapid removal of urea from plasma by hemodialysis will 
47 
 
thus not the significantly lower concentration of urea in aqueous and the 
serum  osmolarity  of  the  blood  is  reduced.  This  reduction  in  plasma  or  
serum osmolarity favours net water movement in the direction of aqueous 
production. As the osmolar gradient intensifies, water flows into the 
aqueous fluid compartment and intraocular pressure rises. 
Thus a rise in intraocular pressure could thus result from the osmotic 
movement of water from the plasma into aqueous. This effect of a decrease 
in blood urea on intraocular pressure as a result of a change in osmolarity 
can be counteracted by adding glucose to dialysate / by combining 
hemodialysis with ultrafiltration. 
2. Colloid osmotic pressure 29 
Fluid removal during ultrafiltration without concomitant albumin 
removal increases colloid osmotic pressure, leading to a fluid shift from 
the aqueous humor to the plasma and a decrease in IOP.  
3. Postdialysis urea rebound (PDUR) and Haematocrit 
PDUR, defined as urea measured 1 hr after dialysis subtracted from 
urea measured at the end of dialysis, was studied by Tovbin et al. 
4. Compromised aqueous outflow facility24 
5. Narrow angles by gonioscopy 21-23  
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OCULAR FINDINGS IN PATIENTS WITH CHRONIC 
KIDNEY DISEASE 
 Chronic kidney disease (CKD) is a progressive loss of renal function 
over a period of months or years. The global rise of CKD is primarily due 
not only to an increased ageing population, but also an association with 
other chronic conditions, including cardiovascular disease, diabetes (DM), 
and cancer. 
Etiology of chronic kidney disease:  
1.  Diabetic nephropathy. 
2. Hypertensive nephropathy.  
3. Glomerulonephritis (inflammation of the kidney).  
4. Pyelonephritis (infection of the kidney). 
5. Systemic lupus erythematosus.  
6. Polycystic kidney disease. 
7. Long-term, regular use of medicines, such as non-steroidal anti-
inflammatory drugs (NSAIDs) 
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Ocular findings in chronic kidney disease: 
1. Conjunctival calcium deposits40 - tiny, discrete, amorphous dull 
white deposits, usually in the interpalpebral area.  
2. Conjunctival erythema, termed the red eyes of uremia, may be 
noted when high plasma phosphate levels induce corneal and 
conjunctival precipitation of calcium pyrophosphate. 
3. Corneal calcium deposits. 
4. Band keratopathy. 
5. Raised intraocular pressure. 
6. Open angle glaucoma. 
7. Hypertensive retinopathy. 
8. Diabetic retinopathy. 
9. Age-related macular degeneration. 
10.  Alport syndrome. 
 
 
  
 
 
 
 
 
PART- II 
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AIM 
1. To assess the correlation of intraocular pressure changes during 
hemodialysis 
2. To assess the correlation of ocular perfusion pressure changes 
during hemodialysis. 
3. To determine that the screening for intraocular pressure and 
characteristic optic nerve head changes and visual field changes of 
glaucoma in end-stage renal disease patients under hemodialysis is 
reasonable and justifiable. 
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INCLUSION CRITERIA: 
Criteria for selection of patient for study was: 
1. Chronic kidney disease patients who are receiving hemodialysis 
therapy for ≥ 1month at Dialysis Unit, Nephrology Department, 
Government Stanley Medical College, Chennai. 
EXCLUSION CRITERIA: 
1. Patients with pre-existing corneal abnormality. 
2. Patients with ocular infection. 
3. Patients with secondary glaucoma, narrow angles. 
4. Patients with high myopia. 
5.       Patients with other ocular diseases, dense cataract, opaque media. 
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MATERIALS AND METHODS 
This study was performed on 100 Chronic Kidney Disease (stage V) 
patients under Hemodialysis treatment, who are attending our Dialysis unit 
in Nephrology Department, Govt. Stanley Medical College, Chennai for 
more than one month were included in this study. 
This study was done in accordance with the rules of ethical 
committee. All patients were informed about the purpose of the study and 
an informed consent was obtained. 
Methods: 
Patients falling inside the inclusion criteria were included in the 
study. A total of 100 patients were selected for this study.  
A detailed Medical, Hemodialysis and Ocular history was collected 
from all the participants and they underwent a thorough physical 
examination, relevant laboratory tests regarding chronic kidney disease 
and complete ocular examinations. 
 All participants are subjected to Intraocular pressure measurement 
by using schiotz tonometry and Blood pressure measurement using 
sphygmomanometer on the upper arm over the brachial artery at three 
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different times during Hemodialysis session. Dialysis was performed with 
session durations of 3 to 5 hours. High-performance dialyzers 
(polysulfone) were used at a blood flow rate of 250 to 400 mL/min, and 
the systemic circulation was accessed through an arteriovenous fistula. 
T1   à  15 minutes before initiation of  hemodialysis  
T2   à  2 hours after initiation of hemodialysis 
T3   à  15 minutes after ending hemodialysis 
 Mean Arterial Pressure (MAP), Ocular Perfusion Pressure (OPP), 
Systolic Ocular Perfusion Pressure (SOPP), Diastolic Ocular Perfusion 
Pressure (DOPP) and Mean Ocular Perfusion Pressure (MOPP) were 
calculated. 
The following formulas will be used to calculate at each time point: 
o Mean arterial pressure (MAP) 
             MAP           =    Diastolic BP + 1/3 (Systolic BP-Diastolic BP) 
o Ocular perfusion pressure (OPP) 
      OPP            =    MAP- IOP 
             SOPP          =    Systolic BP- IOP 
             DOPP         =    Diastolic BP- IOP 
             MOPP        =    2/3(MAP- IOP) 
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Baseline for OPP37: 
o Systolic   OPP  (SOPP) less than  101 mm Hg 
o Diastolic OPP  (DOPP) less than  55 mm Hg 
o Mean      OPP  (MOPP) less than 42 mm Hg 
Each patient underwent detailed 
Clinical ophthalmic examination: 
• Best corrected visual acuity. 
• Slit lamp examination of the anterior segment. 
• Intraocular pressure measurement with schiotz tonometry and 
 Goldman applanation tonometry.  
• Goldman gonioscopy of anterior chamber angle. 
• Visual fields by octopus field analyser. 
• Detailed fundus and optic nerve evaluation by direct 
 ophthalmoscope , 90D and indirect ophthalmoscope 
• Fundus documentation using fundus camera.  
Patients  with  MOPP,  DOPP,  SOPP  below  baseline  and  significant  
variation in IOP were reviewed every 3 months. The patients were 
subjected to all needed glaucoma screening investigations at each visit. 
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A maximum of 3 review visits was done in this study period. 
Patient’s data at each visit were recorded and compared at each follow-up 
visits. 
The data was analysed using SPSS PACKAGE (statistical analysis 
of social science) version 16 and Microsoft excel 2007. 
The following statistical analyses are used in this study 
a.     Percentage analysis was calculated to find the exact percentage of 
respondents 
b.      The mean score was calculated to find the average responses from 
the respondents.  
c.   Standard deviations were also calculated to find the level of 
deviations among the respondents. 
d.    Paired sample 't' test was used to find the significance difference 
between variables. 
This helped in interpretation and interpreted data was summarized in 
percentage. Diagrams and tables were also used to highlight the 
interpretation. 
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OBSERVATIONS 
Age and sex distribution  
S.No Age in years Male Female Total 
1 21-30 11 4 15 
2 31-40 9 10 19 
3 41-50 27 19 46 
4 51-60 12 8 20 
Total  59 41 100 
Percentage  59 41  
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Maximum number of subjects were in the age group of 41-50 years  
Maximum number of subjects were males (59%) 
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41%
Sex Distribution 
Male
Female
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Cause of Chronic Kidney Disease 
 
S.No Cause 
No.of patients 
(n=100) 
Percentage 
(100%) 
1. Diabetes mellitus  40 40.0 
2. Systemic 
hypertension 
25 
25.0 
3. Diabetes & 
hypertension 
11 
11.0 
4. Others  24 24.0 
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Systolic blood pressure  
 
Systolic blood 
pressure 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 126.70 116.90 115.60 
SD 10.736 10.702 8.327 
 
 
Mean change of  systolic blood pressure during time interval 
 
Time  interval 
Mean change of 
systolic blood 
pressure 
SD P-value paired t test 
T1 to T2 -9.80 1.407 0.000 
T2 to T3 -1.30 7.338 0.080 
T1 to T3 -11.10 7.507 0.000 
 
 Mean systolic blood pressure  from T1 to T3 (from the initiation to 
the end of hemodialysis) was found to be decreased by 11.10 mm of Hg.  
It was found to be statistically significant ( p- value: 0.000) 
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Diastolic blood pressure  
 
Diastolic blood 
pressure 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 82.50 74.30 74.00 
SD 7.833 6.705 4.924 
 
 
Mean change of  diastolic blood pressure during time interval 
 
Time  interval 
Mean change of 
diastolic blood 
pressure 
SD P-value paired t test 
T1 to T2 -8.20 3.861 0.000 
T2 to T3 -0.30 5.588 0.593 
T1 to T3 -8.50 6.872 0.000 
 
 
 Mean diastolic blood pressure from T1 to T3 (from the initiation to 
the end of hemodialysis) was found to be decreased by 8.50 mm of Hg.  
It was found to be statistically significant ( p- value: 0.000) 
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Intraocular pressure(IOP) – Right eye 
 
Intraocular 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins 
after ending 
hemodialysis) 
% of eyes 
≤ 16mmHg 38.0 33.0 11.0 
16-20 mmHg 62.0 53.0 27.0 
≥20mmHg 0 14.0 62.0 
Total 100 100.0 100.0 
 
 
 
Intraocular 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins 
after ending 
hemodialysis) 
N 100 100 100 
Mean 16.637 18.07 19.35 
SD 1.5546 1.81 2.06 
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Intraocular pressure – Left eye  
Intraocular 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins 
after ending 
hemodialysis) 
% of eyes 
≤ 16mmHg 45.0 31.0 9.0 
16-20 mmHg 55.0 43.0 38.0 
≥20mmHg 0 26.0 53.0 
Total 100.0 100.0 100.0 
 
 
 
Intraocular 
pressure – left 
eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins 
after ending 
hemodialysis) 
N 100 100 100 
Mean 16.784 18.203 19.284 
SD 1.8886 2.3205 2.2060 
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Mean change of  Intraocular pressure during time interval 
 
 
 
Time  
interval 
Right eye 
 
Left eye 
 
Mean 
change 
of IOP 
SD 
P-value 
paired t 
test 
Mean 
change 
of IOP 
SD 
P-value 
Paired t 
test 
T1 to T2 1.435 .4527 0.000 1.419 .9005 0.000 
T2 to T3 1.285 .5615 0.000 1.081 .8394 0.000 
T1 to T3 2.720 .8828 0.000 2.500 1.0477 0.000 
 
 Mean  IOP   from  T1  to  T3  (from  the  initiation  to  the  end  of  
hemodialysis) was found to be increased by 2.7mm of Hg in both eyes.  
It was found to be statistically significant (RE p- value: 0.000, LE p-value 
0.000) 
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Mean arterial pressure (MAP) 
Mean arterial 
pressure 
(MAP) 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins 
after ending 
hemodialysis) 
% of eyes 
≤90mmHg 1.0 67.0 60.0 
90-110mmHg 89.0 33.0 40.0 
≥111mmHg 10.0 0 0 
Total 100.0 100 100 
 
 
 
Mean arterial 
pressure 
(MAP) 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 97.656 88.236 87.522 
SD 8.0791 8.0950 5.8831 
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Mean change of  Mean arterial pressure (MAP) during time interval 
Time  interval 
Mean 
change of 
MAP 
SD P-value paired t test 
T1 to T2 -9.420 2.0280 0.000 
T2 to T3 -0.714 6.1106 0.245 
T1 to T3 -10.134 6.5030 0.000 
 
 Mean arterial pressure (MAP)  from T1 to T3 (from the initiation to 
the end  of hemodialysis) was found to be decreased by 10.13 mm of Hg. 
It  was found to be statistically significant ( p- value: 0.000) 
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Ocular perfusion pressure (OPP) –  Right eye 
Ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 70 mmHg 1.0 69.0 60.0 
70-80  mmHg 68.0 21.0 40.0 
≥80mmHg 31.0 10.0 0 
Total 100.0 100.0 100.0 
  
 
 
Ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 81.045 69.990 68.201 
SD 7.8347 7.8999 6.7689 
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Ocular perfusion pressure –  Left eye  
Ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 70 mmHg 1.0 69.0 60.0 
70-80  mmHg 68.0 21.0 40.0 
≥80mmHg 31.0 10.0 0 
Total 100.0 100.0 100 
 
 
 
Ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours 
after initiation 
of hemodialysis) 
T3 (15mins 
after ending 
hemodialysis) 
N 100 100 100 
Mean 80.900 69.851 68.186 
SD 7.1442 7.8713 6.7353 
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Mean change of Ocular perfusion pressure (OPP) during time interval 
 
 
Time  
interval 
Right eye 
 
Left eye 
 
Mean 
change 
of OPP 
SD 
P-value 
paired t 
test 
Mean 
change 
of OPP 
SD 
P-value 
Paired 
t test 
T1 to T2 -11.055 1.5728 0.000 -11.049 2.0055 0.000 
T2 to T3 -1.789 6.5732 0.008 -1.665 6.5306 0.012 
T1 to T3 -12.844 7.0538 0.000 -12.714 6.8398 0.000 
 
 
Ocular  perfusion pressure from T1 to T3 (from the initiation to the 
end of hemodialysis) was found to be decreased by 12.84 mm Hg in both 
eyes. It was found to be statistically significant (RE p- value: 0.000, LE  
p-value 0.000) 
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Systolic ocular perfusion pressure (SOPP) – Right eye 
 
Systolic ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 91 mmHg 0 20.0 42.0 
91 - 101 mmHg 0 42.0 16.0 
≥ 102 mmHg 100.0 38.0 42.0 
Total 100.0 100.0 100.0 
  
 
 
 
Systolic ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 110.489 99.524 96.573 
SD 10.6946 10.6343 8.8659 
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Systolic ocular perfusion pressure – Left eye  
Systolic ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 91 mmHg 0 22.0 43.0 
91 - 101 mmHg 0 40.0 15.0 
≥ 102 mmHg 100.0 38.0 42.0 
Total  100.0 100.0 100.0 
 
 
 
Systolic ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 110.328 99.415 96.616 
SD 9.9877 10.5267 8.7909 
 
0 0 0
100
0
22
40 38
0
43
15
42
0
20
40
60
80
100
120
≤ 91 mmHg 91 - 101 mmHg ≥ 102 mmHg
%
 o
f e
ye
s
Systolic ocular perfusion pressure - Left eye
T1
T2
T3
72 
 
 
Mean change of  Systolic Ocular perfusion pressure (SOPP) during 
time interval 
 
 
Time  
interval 
Right eye 
 
Left eye 
 
Mean 
change SD 
P-value 
paired t 
test 
Mean 
change SD 
P-value 
Paired 
t test 
T1 to T2 -10.965 2.2154 0.000 -10.913 2.3815 0.000 
T2 to T3 -2.951 7.3428 0.000 -2.799 7.3481 0.000 
T1 to T3 -13.916 7.9550 0.000 -13.712 7.7918 0.000 
 
Systolic ocular perfusion pressure from T1 to T3 (from the initiation 
to the end of hemodialysis) was found to be decreased by 13.92  mm Hg 
in both eyes. It was found to be statistically significant (RE p- value: 
0.000, LE p-value 0.000) 
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Diastolic ocular perfusion pressure (DOPP) – Right eye 
 
Diastolic 
ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 51 mmHg 0 20.0 42.0 
52 - 55mmHg 1.0 41.0 16.0 
≥ 56 mmHg 99.0 39.0 42.0 
Total 100.0 100.0 100.0 
 
 
 
Diastolic 
ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 66.889 56.354 54.873 
SD 6.4941 6.7739 6.1247 
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Diastolic ocular perfusion pressure – Left eye  
Diastolic 
ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 51 mmHg 0 22.0 43.0 
52 - 55mmHg 1.0 45.0 15.0 
≥ 55 mmHg 99.0 33.0 42.0 
Total 100.0 100.0 100.0 
 
 
 
Diastolic 
ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 66.744 56.235 54.916 
SD 5.8260 6.8524 6.1358 
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Mean change of  Diastolic ocular perfusion pressure (DOPP) during 
time interval 
 
 
Time  
interval 
Right eye 
 
Left eye 
 
Mean 
change SD 
P-value 
paired t 
test 
Mean 
change SD 
P-value 
Paired 
t test 
T1 to T2 -10.535 3.2280 0.000 -10.509 3.5680 0.000 
T2 to T3 -1.481 6.1205 0.017 -1.319 6.1056 0.033 
T1 to T3 -12.016 6.9660 0.000 -11.828 6.8300 0.000 
 
 
 Diastolic ocular perfusion pressure from T1 to T3 (from the 
initiation to the end of hemodialysis) was found to be decreased by 12.016 
mm Hg in both eyes. It was found to be statistically significant  
(RE p- value: 0.000, LE p-value 0.000) 
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Mean  ocular perfusion pressure (MOPP) – Right eye 
Mean  ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 42 mmHg 0 35.0 47.0 
42 - 50 mmHg 16.0 32.0 17.0 
≥ 51 mmHg 84.0 33.0 36.0 
Total 100.0 100.0 100.0 
  
 
 
Mean  ocular 
perfusion 
pressure – 
Right eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 53.918 46.634 45.328 
SD 5.1937 5.4039 4.5408 
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Mean  ocular perfusion pressure –  Left eye  
 
Mean  ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
% of eyes 
T2 (2 hours after 
initiation of 
hemodialysis ) 
% of eyes 
T3 (15mins after 
ending 
hemodialysis) 
% of eyes 
≤ 42 mmHg 0 22.0 47.0 
42 - 50 mmHg 13.0 45.0 20.0 
≥ 50 mmHg 87.0 33.0 33.0 
Total 100.0 100.0 100.0 
 
 
 
Mean  ocular 
perfusion 
pressure – Left 
eye 
T1 (15mins 
before 
hemodialysis) 
T2 (2 hours after 
initiation of 
hemodialysis ) 
T3 (15mins after 
ending 
hemodialysis) 
N 100 100 100 
Mean 53.892 46.647 45.302 
SD 4.7592 5.2583 4.5284 
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Mean change of  Mean ocular perfusion pressure (MOPP) during time 
interval 
 
 
 
Time  
interval 
Right eye 
 
Left eye 
 
Mean 
change SD 
P-value 
paired t 
test 
Mean 
change SD 
P-value 
Paired 
t test 
T1 to T2 -7.284 1.6074 0.000 -7.245 1.7009 0.000 
T2 to T3 -1.306 4.2474 0.003 -1.345 4.2267 0.002 
T1 to T3 -8.590 4.7445 0.000 -8.590 4.5734 0.000 
 
 Mean ocular perfusion pressure from T1 to T3 (from the initiation to 
the end of hemodialysis) was found to be decreased by 8.590 mm Hg in 
both eyes. It was found to be statistically significant (RE p- value: 0.000, 
LE p-value 0.000) 
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Applying the thresholds used in the Barbados eye studies for evaluating 
relative risk of open angle glaucoma 
Percentage of Ocular perfusion pressure changes below threshold 
(Total 100 patients ) 
 T1 (15mins 
before 
hemodialysis) 
%  of eyes 
T2 (2 hours after 
initiation of 
hemodialysis) 
%  of eyes 
T3 (15mins after 
ending 
hemodialysis) 
%  of eyes 
Right  
eye 
Left 
eye 
Right 
eye 
Left 
eye 
Right 
eye 
Left 
eye 
Mean 
ocular 
perfusion 
pressure  
≤42mmHg 
0 0 36 31 48 48 
Diastolic 
ocular 
perfusion 
pressure  
≤55mmHg 
0 0 63 66 58 58 
Systolic 
ocular 
perfusion 
pressure  
≤101mmHg 
0 0 63 60 58 58 
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RESULTS 
 A total of 200 eyes of 100 subjects were recruited in our study. They 
were in the age group ranging from 25 to 62 years. 
All the recruited patients were within inclusion criteria of our study. 
The following were the results of our study: 
1. Mean IOP from the initiation to the end of hemodialysis was found 
to be increased by 2.7mm Hg in both eyes. It was found to be 
statistically significant (RE p- value: 0.000, LE p-value 0.000) 
2. Mean  arterial  pressure  (MAP)  from  the  initiation  to  the  end  of  
hemodialysis  was found to be decreased by 10.13 mm Hg. It  was 
found to be statistically significant ( p- value: 0.000) 
3. Ocular perfusion pressure from the initiation to the end of 
hemodialysis was found to be decreased by 12.84 mm Hg in both 
eyes. It was found to be statistically significant (RE p- value: 0.000, 
LE p-value 0.000) 
4. Systolic ocular perfusion pressure from the initiation to the end of 
hemodialysis was found to be decreased by 13.92 mm Hg in both 
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eyes. It was found to be statistically significant (RE p- value: 0.000, 
LE p-value 0.000) 
5. Diastolic ocular perfusion pressure from the initiation to the end of 
hemodialysis was found to be decreased by 12.016 mm Hg in both 
eyes. It was found to be statistically significant (RE p- value: 0.000, 
LE p-value 0.000) 
6. Mean ocular perfusion pressure from the initiation to the end of 
hemodialysis was found to be decreased by 8.59 mm Hg in both 
eyes. It was found to be statistically significant (RE p- value: 0.000, 
LE p-value 0.000) 
7. Applying the thresholds used in the Barbados eye studies for 
evaluating relative risk of open angle glaucoma development and 
progression: 
a.  58 % of both eyes had a Systolic ocular perfusion pressure of  ≤ 
101mmHg  
b. 58  %  of  both  eyes  had  a  Diastolic  ocular  perfusion  pressure  of   ≤ 
55mmHg 
c. 48% both eyes had a Mean ocular perfusion pressure of  ≤ 
42mmHg. 
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Patients were asked for follow-up based on their findings. 
 Among the 100 patients, 58 patients had Ocular perfusion pressure 
(OPP, MOPP, SOPP, DOPP) below baseline at their first visit 
examination. Hence they were followed up every 3 months. 
 Among 58 patients advised follow-up, 46 attended regular follow-up 
of maximum 3 visits every 3 months during our study period.  
 They underwent the needed ocular and systemic examinations in all 
the 3 visits and the results were compared. 12 Patients did not attend 
complete follow-up as per advice. In these 12 patients 2 patients had early 
field changes and optic nerve head changes but we lost follow up of them 
in following visits.  
 At the end of this 2 year period, 4 of the 46 patients were found to 
develop early glaucomatous field defects and early optic nerve head 
changes in both eyes at follow-up visits compared to normal fields and 
optic nerve head in their initial visits. They were also found to have 
increased in intraocular pressure (≥ 21mm Hg in both eyes) compared to 
the initial reading. (FOLLOW UP CHART IN ANNEXURE) 
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GLAUCOMATOUS FIELD DEFECTS 
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GLAUCOMATOUS OPTIC NERVE HEAD CHANGES 
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DISCUSSION 
Our study reveals statistically significant increase in intraocular 
pressure during hemodialysis. 
Our study also reveals that there is statistically significant decrease 
in ocular perfusion pressure, diastolic ocular perfusion pressure, systolic 
ocular perfusion pressure and mean ocular perfusion pressure during 
hemodialysis. 
Similar results were also given by other related studies: 
Burn  RA  et  al25 in 1973 observed an IOP rise in one-third of the 
patients treated with long-term HD. 
Jennifer Hu et al.18 study in 2013 have also reported that statistically 
significant rise in IOP by 3.1mmHg during Hemodialysis session. Our 
study also concludes the same that there is a significant increase in 
intraocular pressure by 2.7 mmHg during a hemodialysis session.   
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Jennifer Hu et al. study 
2013 
Chhabra 
S C et al. 
study 
1988 
OUR STUDY 
 RE LE MEAN  RE LE 
OBSERVATION IOP before 
HD 19.1 
mmHg  
IOP before 
HD 17.7 
mmHg 
Mean IOP 
before HD 
16.8 ± 0.29 
mmHg 
IOP 15 mins 
before HD 
16.6 mmHg 
IOP 15 mins 
before HD 
16.8 mmHg 
IOP at 2 
hours after 
starting HD 
21.0mmHg 
IOP at 2 
hours after 
starting HD 
19.2mmHg 
Mean IOP 
at 2 hours 
of HD 16.9 
± 0.34 mm 
Hg 
IOP at 2 
hours after 
starting HD 
18.07mmHg 
IOP at 2 
hours after 
starting HD  
18.2mmHg 
IOP after 
HD 22.2 
mmHg 
IOP after 
HD 20.8 
mmHg 
Mean IOP 
at end of 
HD 16.7 ± 
0.33 
mmHg 
IOP 15 mins 
after ending 
HD 
19.35mmHg 
IOP 15 mins 
after ending 
HD 
19.28mmHg 
INFERENCE IOP significantly 
increased by 3.1mmHg 
in both eyes (p<0.001) 
No 
statistically 
significant 
difference 
in IOP. 
(P<0.05) 
IOP significantly increased 
by 2.7mmHg in both eyes 
(p<0.001) 
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Chhabra S C et al.41 study in 1988 reported that there was no 
statistically significant difference in IOP (P<0.05). But in one patient with a 
borderline intraocular pressure in one eye & raised intraocular pressure in the 
other eye, there was a considerable rise (10.1 mm Hg in one eye & 7.7 mm 
Hg in the other eye) in intraocular pressure at 2 hours & comparatively 
smaller rise (5.6 mm Hg in one eye & 3.7 mm Hg in the other eye) at the end 
of dialysis. 
The reason behind raise in IOP during hemodialysis has been 
explained as an effect secondary to a rapid decrease in plasma osmolarity and 
a relative increase in intracellular compared with extracellular urea 
concentration. This rapid change results in a gradient between plasma and 
ocular compartments, inducing a shift of extracellular fluid from the blood to 
the anterior chamber. And also increase in IOP is more pronounced in eyes 
with compromised aqueous outflow. 
The evidence is increasing that IOP and BP instability may be 
associated with glaucoma. Variations in ocular perfusion pressure due to IOP 
and BP fluctuations may play a role in glaucoma development or progression. 
Fluctuation of ocular perfusion pressure is one of the known risk 
factors of development and progression of Normal tension glaucoma. 
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Jennifer Hu et al in 2013 have reported that significant decrease in 
OPP, MOPP, DOPP, SOPP occur during the active process of Hemodialysis. 
Our study also concluded that ocular perfusion pressure is significantly 
reduced during a hemodialysis session. 
  Jennifer Hu et al. 
study 2013 
OUR STUDY 
OBSERVATION 
 
Mean 
change 
from start 
to end of 
HD 
session 
(mmHg) 
p-value 
Mean 
change 
from start 
to end of 
HD 
session 
(mmHg) 
p- 
value 
OPP RE -8.9 0.002 -12.8 <0.001 
LE -8.7 0.004 -12.7 <0.001 
SOPP RE -11.4 0.01 -13.9 <0.001 
LE -11.0 0.02 -13.7 <0.001 
DOPP RE -7.7 0.001 -12.01 <0.001 
LE -7.5 0.002 -11.8 <0.001 
MOPP RE -7.0 <0.0013 -8.6 <0.001 
LE -6.8 0.001 -8.6 <0.001 
INFERENCE 
All OPP measures 
significantly 
decreased (p≤0.02) 
All OPP measures 
significantly 
decreased 
(p<0.001) 
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 According to the thresholds used in the Barbados eye studies for 
evaluating the relative risk of open angle glaucoma : 
  Jennifer Hu et al. 
study 2013 
OUR STUDY 
OBSERVATION  
Percentage of eyes 
below baseline 
threshold (%) 
Percentage of eyes 
below baseline 
threshold (%) 
 
Right 
eye 
Left eye 
Right 
eye 
Left eye 
SOPP 53 46 58 58 
DOPP 71 73 58 58 
MOPP 63 65 51 51 
 
 Reasons of ocular perfusion pressure fluctuation during 
hemodialysis session are as follows : 
· Autoregulation, the ability of vascular bed to change the vascular 
resistance in response to the perfusion pressure changes to maintain 
a relatively constant blood flow- plays a crucial role if undergoes 
impairment. 
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· Fluctuation changes of BP secondary to fluid shifts during active 
process of hemodialysis. 
Our study found that there is statistically significant fluctuation in 
ocular perfusion pressure during a hemodialysis session. Accordingly, 
hemodialysis patients might have frequent IOP and OPP fluctuations 
during long-term, frequent sessions of hemodialysis, each lasting several 
hours may subsequently increase patients risk for glaucoma development 
and progression. 
Survival rates of hemodialysis patients have been studied which 
showed that there is an improvement in life expectancy of end-stage renal 
disease patients after  hemodialysis initiation44. 
Barbados eye study demonstrated that increased risk of glaucoma 
development at 4 to 9 years in patients with low baseline OPP. 
Our study found that when patients with ocular perfusion pressure 
below baseline were regularly followed up over the study period of 2 
years, 6 patients of the 58 patients developed early glaucomatous field 
defects and early optic nerve head changes in both eyes at follow-up visits 
compared to normal fields and optic nerve head in their initial visits.  
93 
 
According to Barbados eye study risk of glaucoma development was 
demonstrated as 4-9 years following low baseline OPP. Even though in our 
study we followed up patients only for 2 years post hemodialysis, 6 out of 
58 patients developed early glaucoma field changes and optic nerve head 
changes. Which  comes around 10%   
Hence our study reveals the importance of screening and monitoring 
of intraocular pressure and characteristic early optic nerve head changes 
and early visual field changes of glaucoma in end-stage renal disease 
patients who are on hemodialysis.  
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CONCLUSION 
Glaucoma is one of the preventable causes of irreversible visual 
impairment, on diagnosis and treatment at early stages. Intraocular 
pressure and Ocular perfusion pressure has been shown to be known risk 
factors for open angle glaucoma. 
The evidence is increasing that IOP , BP and ocular perfusion 
pressure instability may be associated with glaucoma. Variations in ocular 
perfusion pressure due to IOP and BP fluctuations may play a role in 
Normo-tension glaucoma development or progression. 
Transient changes in intraocular pressure and ocular perfusion 
pressure during hemodialysis has been studied only by few studies  
Our study found that there is transient increase in intraocular 
pressure to around 3mmHg during hemodialysis and transient decrease in 
ocular perfusion pressure during hemodialysis. At  the  end  of  this  2  year  
study period, 6 of the 58 patients were found to develop early 
glaucomatous field defects and early optic nerve head changes in both eyes 
at follow-up visits compared to normal fields and optic nerve head in their 
initial visits. Which comes around 10%   
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 This study will help in better management of known glaucoma 
patients when they require hemodialysis. That way the impending 
ischemic insult of the optic nerve head can be avoided. 
Chronic kidney disease patients with diabetes mellitus, systemic 
hypertension, glaucoma suspects, family history of glaucoma may benefit 
from intraocular pressure and blood pressure monitoring during a 
hemodialysis session.   
Hence our study reveals the importance of screening and monitoring 
of intraocular pressure and characteristic early optic nerve head changes 
and early visual field changes of glaucoma in end-stage renal disease 
patients who are on hemodialysis. So doing a routine screening of IOP and 
glaucoma changes before initiation of hemodialysis therapy is reasonable 
and justifiable. 
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PROFORMA 
NAME:                                                                     AGE/SEX:                         
DATE: 
IP/OP NO: 
ADDRESS: 
 
COMPLAINTS: 
 
H/O CKD- 
Duration    :                                            stage:                                  GFR: 
Treatment : 
H/O other co-morbidities: 
Diabetes milletus: 
Hypertension: 
Glaucoma :                
OTHERS: 
SYSTEMIC  EXAMINATION: 
Bp : 
 
OCULAR EXAMINATION:                RE                                                       LE 
Vn                                                            
Vn PH                               
CONJUCTIVA: 
CORNEA: 
ANTERIOR CHAMBER 
IRIS 
PUPIL 
LENS 
 
FUNDUS                                                   RE                                                   LE 
MEDIA 
DISC 
VESSELS 
MACULA 
BACKGROUND 
DIAGNOSTIC TEST:                     RE                                          LE 
IOP 
GONIO 
PERIMETRY     LE                                                                 RE 
 
 
 
INVESTIGATIONS: 
RBS:                                                                                  Sr.urea:                                                                                           
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ABBREVATIONS 
S.NO   - Serial Number 
M    - Male 
F   - Female 
RE    - Right Eye 
LE    - Left Eye 
MMHG  - Millimeters of mercury 
CKD    - Chronic Kidney Disease 
HD    - Hemodialysis  
IOP    - Intraocular Pressure  
BP    - Blood Pressure 
DBP    - Diastolic Blood Pressure 
SBP    - Systolic Blood Pressure 
MAP    - Mean Arterial Pressure  
OPP    - Ocular Perfusion Pressure  
 SOPP   - Systolic Ocular Perfusion Pressure 
DOPP   - Diastolic Ocular Perfusion Pressure  
MOPP  -         Mean Ocular Perfusion Pressure 
ONH   -         Optic Nerve Head 
POAG  -         Primary Open Angle Glaucoma 
OAG   -         Open Angle Glaucoma 
ARMD  - Age Related Macular Degeneration  
DM    - Diabetes Mellitus 
HT    - Hypertension  
PDUR  - Post Dialysis Urea Rebound  
RVA   - Retinal Vessel Analyser  
NSAIDs   - Non- Steroidal Anti- Inflammatory Drugs  
GAG   - Glycosoaminoglycans 
ATP    - Adenosine Tri Phosphate  
SVP    - Systemic Venous Pressure  
LALES                    - Los Angeles Latino Eye Study  
MASTER	CHART	-	I	
S.NO NAME AGE 
/SEX 
SYS. 
ILL 
BP (mmHg) IOP (mmHg) MAP (mmHg) MOPP (mmHg) OPTIC 
NERVEHEAD 
VISUAL 
FIELD T1 T2 T3 T1 T2 T3 
T1 T2 T3 RE LE RE LE RE LE T1 T2 T3 RE LE RE LE RE LE RE LE RE LE 
1. Venkatesh 47/M SHT 140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 20.9 106.6 96.6 96.6 59.5 58.4 51.8 50.6 50.7 49.8 0.3 0.3 N N 
2. VargheseThomas 34/M - 130/80 120/80 120/80 14.6 14.3 15.9 14.3 15.9 14.3 96.6 93 93 54.6 54.8 51.4 52.4 51.1 52.1 0.3 0.3 N N 
3. Kamala 51/F SHT/DM2 140/90 130/80 130/80 18.9 17.3 20.6 18.9 21.9 20.6 106.6 96.6 96.6 54.8 59.5 50.6 51.8 49.8 50.7 0.3 0.3 N N 
4 . Sasikumar  30/M - 120/80 110/70 110/70 18.9 18.9 20.6 20.9 20.9 20.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
5. SanthoshKumar 35/M - 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
6. Vinothraj  45/M DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
7. Samuvel Raja  50/M DM2 120/80 110/70 100/70 18.9 17.3 19.6 18.9 20.1 20.1 93 83 80 49.4 50.4 42.0 42.7 39.9 39.9 0.3 0.3 N N 
8. Jayalakshmi 46/F DM2 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
9. Rajamuthaiah  49/M DM2/SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
10. Gnanaprakasan  50/M  DM2 120/80 110/70 110/70 17.3 15.9 19.6 17.3 20.1 18.9 93 83 83 50.4 51.4 42.0 43.8 41.6 41.3 0.3 0.3 N N 
11. Chinnapaiyan 50/M DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
12. Kotti 45/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
13. Vasanthi  47/F DM2 130/80 120/80 120/80 14.6 14.3 15.9 14.3 15.9 14.3 96.6 93 93 54.6 54.8 51.4 52.4 51.1 52.1 0.3 0.3 N N 
14. Silambarasan 43/M - 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
15. Kotteshwaran 46/M SHT 140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 20.9 106.6 96.6 96.6 59.5 58.4 51.8 50.6 50.7 49.8 0.3 0.3 N N 
16. Sekar  40/M - 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 20.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
17. Lakshmanan 47/M SHT 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 20.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
18. Parthiban 24/M SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
19. Savarimuthu 40/M DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
20. Kannnan  44/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
21. Murugan 46/M DM2/SHT 120/80 110/70 120/80 14.6 15.9 14.6 15.9 14.6 15.9 93 83 93 52.2 51.4 45.6 44.7 52.2 51.4 0.3 0.3 N N 
22. Thenmozhi 49/F DM2 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
23. Menaka 57/F DM2 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
24. Ganesh kumar 27/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
25. Eswaraiya  55/M  DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
26. Dinesh 21/M - 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
27. Maruthai  50/M SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
28. Narayanan 28/M SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
29. Mohana 47/F - 120/80 110/70 110/70 15.9 15.6 17.3 17.0 18.9 19.6 93 83 83 51.4 51.6 43.8 44.0 41.6 41.9 0.3 0.3 N N 
30. Valli 50/F - 120/80 120/80 120/80 15.9 17.3 15.9 17.3 15.9 17.3 93 93 93 51.4 50.4 51.4 50.4 51.4 50.4 0.3 0.3 N N 
31. Anbu  49/M - 120/80 110/70 110/70 17.3 15.6 18.9 17.0 20.6 19.6 93 83 83 50.4 51.6 41.9 44.0 41.3 41.9 0.3 0.3 N N 
32. Mahalingam  43/M DM2 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
33. Ganesh  55/M DM2/SHT 120/80 110/70 120/80 14.6 15.9 14.6 15.9 14.6 15.9 93 83 93 52.2 51.4 45.6 44.7 52.2 51.4 0.3 0.3 N N 
34. Ramesh 30/M - 120/80 110/70 110/70 17.3 15.9 19.6 17.3 20.1 18.9 93 83 83 50.4 51.4 42.0 43.8 41.6 41.3 0.3 0.3 N N 
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35. Amelarpara mary 57/F SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
36. Chandrasekar 25/M - 130/80 120/80 120/80 14.6 14.3 15.9 14.3 15.9 14.3 96.6 93 93 54.6 54.8 51.4 52.4 51.1 52.1 0.3 0.3 N N 
37. Mala 30/F - 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
38 Periyandi 62/M DM2 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
39 Chalapathy 40/M DM2 120/80 110/70 110/70 15.9 15.6 17.3 17.0 18.9 19.6 93 83 83 51.4 51.6 43.8 44.0 41.6 41.9 0.3 0.3 N N 
40. Sankaraselvi 40/F SHT 140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 96.6 59.5 58.4 51.8 50.6 50.7 49.8 0.3 0.3 N N 
41.  Padmavathi 42/F DM2 120/80 110/70 120/80 14.6 15.9 14.6 15.9 14.6 15.9 93 83 93 52.2 51.4 45.6 44.7 52.2 51.4 0.3 0.3 N N 
42. Banu  48/F DM2 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
43. Murugan 46/M DM2/SHT 120/80 110/70 110/70 17.3 15.6 18.9 17.0 20.6 19.6 93 83 83 50.4 51.6 41.9 44.0 41.3 41.9 0.3 0.3 N N 
44 MohamedImbran 57/M DM2 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
45. George joshva  39/M DM2 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.4 0.4 N N 
46 Savitha 30/F - 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
47. Narayanan 46/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
48. Latha 30/F - 120/80 120/80 120/80 15.9 17.3 15.9 17.3 15.9 17.3 93 93 93 51.4 50.4 51.4 50.4 51.4 50.4 0.3 0.3 N N 
49. Murugan  45/M DM2 120/80 110/70 110/70 15.9 15.6 17.3 17.0 18.9 19.6 93 83 83 51.4 51.6 43.8 44.0 41.6 41.9 0.3 0.3 N N 
50. Ramesh  28/M SHT 140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 96.6 59.5 58.4 51.8 50.6 50.7 49.8 0.3 0.3 N N 
51. Krishnamoorthy 52/M DM2 120/80 110/70 110/70 17.3 15.6 18.9 17.0 20.6 19.6 93 83 83 50.4 51.6 41.9 44.0 41.3 41.9 0.3 0.3 N N 
52. Shylaja 30/F - 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
53. Govindasamy  40/M DM2 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
54. Babitha dass  49/F - 120/80 110/70 110/70 17.3 15.6 18.9 17.0 20.6 19.6 93 83 83 50.4 51.6 41.9 44.0 41.3 41.9 0.3 0.3 N N 
55. Dhandapani  47/M DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
56. Paramasivan  28/M DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
57. Punitha  50/F - 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
58. Rubashree 21/F DM/SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
59. Athish   30/M - 120/80 110/70 110/70 17.3 15.9 19.6 17.3 20.1 18.9 93 83 83 50.4 51.4 42.0 43.8 41.6 41.3 0.3 0.3 N N 
60. Varalakshmi 42/F DM2  140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 96.6 59.5 58.4 51.8 50.6 50.7 49.8 0.3 0.3 N N 
61. Vasuki 48/F SHT 130/80 120/80 120/80 14.6 14.3 15.9 14.3 15.9 14.3 96.6 93 93 54.6 54.8 51.4 52.4 51.1 52.1 0.3 0.3 N N 
62. Gomathi 43/F - 140/90 130/80 130/80 18.9 17.3 20.6 18.9 21.9 20.6 106.6 96.6 96.6 54.8 59.5 50.6 51.8 49.8 50.7 0.3 0.3 N N 
63. Ramu 32/M SHT 120/80 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
64. Kumar  47/M - 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
65. Manogaran  57/M - 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
66. Manikkam  57/M  SHT 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
67. Saidhani   42/F - 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
68. Babarao 49/M DM2 120/80 110/70 100/70 18.9 17.3 19.6 18.9 20.1 20.1 93 83 80 49.4 50.4 42.0 42.7 39.9 39.9 0.3 0.3 N N 
69. Prakasam  50/m  120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
70. Menaka   45/F - 120/70 110/70 110/70 17.3 17.3 19.6 18.9 20.6 20.1 87 83 83 46.4 46.4 42.0 42.7 41.6 39.9 0.3 0.3 N N 
71. Thenmozhi 50/F - 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
72. Vasanthi  45/F SHT 120/80 110/70 110/70 15.9 15.6 17.3 17.0 18.9 19.6 93 83 83 51.4 51.6 43.8 44.0 41.6 41.9 0.3 0.3 N N 
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73. Selvi  40/F  - 120/80 110/70 100/70 18.9 17.3 19.6 18.9 20.1 20.1 93 83 80 49.4 50.4 42.0 42.7 39.9 39.9 0.3 0.3 N N 
74. Kannan  31/M  - 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
75. Velu  46/M  DM2 120/80 110/70 110/70 17.3 15.6 18.9 17.0 20.6 19.6 93 83 83 50.4 51.6 41.9 44.0 41.3 41.9 0.3 0.3 N N 
76. Annammal  52/F SHT 140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 93 59.5 58.4 51.8 50.6 48.2 47.4 0.3 0.3 N N 
77. Jayalakshmi 55/F DM2 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
78. Williams Durai  38/M  DM2  120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
79. Vijaya  40/F SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
80. Ramesh  40/M DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
81. Forook  50/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
82. Shenbagavalli  60/F  DM2/SHT 120/80 110/70 120/80 14.6 15.9 14.6 15.9 14.6 15.9 93 83 93 52.2 51.4 45.6 44.7 52.2 51.4 0.3 0.3 N N 
83. Elizabeth  53/F DM2 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
84. Jothi 40/F DM2 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
85. Joseph 50/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
86. Parveen 32/F DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
87. Mohd. roshan  56/M DM2  120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
88. Balaraman  48/M SHT  120/80 110/70 110/70 15.9 15.6 17.3 17.0 18.9 19.6 93 83 83 51.4 51.6 43.8 44.0 41.6 41.9 0.3 0.3 N N 
89. Lakshmiammal  53/F DM/SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
90. Punitha 50/F DM2 120/80 110/70 110/70 17.3 15.9 19.6 17.3 20.1 18.9 93 83 83 50.4 51.4 42.0 43.8 41.6 41.3 0.3 0.3 N N 
91. Kanagaraj 45/M  DM2 120/80 110/70 110/70 14.6 14.3 15.9 15.6 17.3 17.0 93 83 83 52.2 52.4 44.7 44.9 43.8 44 0.3 0.3 N N 
92. Shankar 42/M SHT 140/90 130/80 110/70 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 83 59.5 58.4 51.8 50.6 41.6 40.7 0.3 0.3 N N 
93. Chindhanaiselvi 56/F DM2 130/80 120/80 120/80 14.6 14.3 15.9 14.3 15.9 14.3 96.6 93 93 54.6 54.8 51.4 52.4 51.1 52.1 0.3 0.3 N N 
94. Ramu 40/M DM2 120/80 110/70 110/70 17.3 17.3 18.9 19.6 20.6 20.1 93 83 83 50.4 50.4 41.9 42.0 41.3 41.6 0.3 0.3 N N 
95. Bhavani 46/F SHT 140/90 130/80 130/80 17.3 18.9 18.9 20.6 20.6 21.9 106.6 96.6 93 59.5 58.4 51.8 50.6 48.2 47.4 0.3 0.3 N N 
96. Jaikumar  53/M DM2 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
97. Marimuthu  57/M DM2 120/70 110/70 110/70 18.9 18.9 20.6 21.9 21.9 21.9 93 83 83 49.4 49.4 41.6 40.7 40.7 40.7 0.3 0.3 N N 
98. Gajalakshmi 45/F SHT 150/100 140/90 130/80 17.3 18.9 18.9 18.9 20.6 20.6 116.6 106.6 96.6 66.2 65.1 58.4 58.4 50.6 50.6 0.3 0.3 N N 
99. Malarkodi 51/F DM2  120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
100. Sudha 40/F DM2 120/80 110/70 120/80 14.6 14.3 15.9 15.6 17.3 17.0 93 83 93 52.2 52.4 44.7 44.9 50.6 50.7 0.3 0.3 N N 
 
MASTER CHART - 2 
S.N
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RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE 
1. Venkatesh 47/M 6/24 6/24 89.3 87.7 77.7 76 76 74.7 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
2. VargheseThomas 34/M 6/24 6/24 82 82.3 77.1 78.7 77.1 78.7 65.4 65.7 64.1 65.7 64.1 65.7 115.4 115.7 104.1 105.7 104.1 105.7 
3. Kamala 51/F 6/36 6/18 87.7 89.3 76 77.7 74.7 76 71.1 72.7 59.4 61.1 58.1 59.4 121.1 122.7 109.4 111.1 108.1 109.4 
4 . Sasikumar  30/M 6/12 6/12 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
5. SanthoshKumar 35/M 6/6 6/6 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
6. Vinothraj  45/M 6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
7. Samuvel Raja  50/M 6/12 6/12 74.1 75.7 63.4 64.1 59.9 59.9 61.1 62.7 50.4 51.1 49.9 49.9 101.1 102.7 90.4 91.1 79.9 79.9 
8. Jayalakshmi 46/F 6/24 6/24 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 94.1 94.4 102.7 103 
9. Rajamuthaiah  49/M 6/9 6/9 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
10. Gnanaprakasan  50/M  6/12 6/12 75.7 77.1 63.4 65.7 62.9 64.1 62.7 64.1 50.4 52.7 49.9 51.1 102.7 104.1 90.4 92.7 89.9 91.1 
11. Chinnapaiyan 50/M 6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
12. Kotti 45/M 6/24 6/9 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
13. Vasanthi  47/F 6/24 6/36 82 82.3 77.1 78.7 77.1 78.7 65.4 65.7 64.1 65.7 64.1 65.7 115.4 115.7 104.1 105.7 104.1 105.7 
14. Silambarasan 43/M 6/9 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
15. Kotteshwaran 46/M 6/18 6/12 89.3 87.7 77.7 76 76 74.7 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
16 Sekar  40/M 6/9 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
17. Lakshmanan 47/M 6/24 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
18. Parthiban 24/M 6/18 6/12 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
19. Savarimuthu 40/M 6/9 6/9 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
20. Kannnan  44/M 6/18 6/18 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
21. Murugan 46/M 6/24 6/12 78.4 77.1 68.4 67.1 78.4 77.1 65.4 64.1 55.4 54.1 65.4 64.1 105.4 104.1 95.4 94.1 105.4 104.1 
22. Thenmozhi 49/F 6/24 6/24 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 94.1 94.4 102.7 103 
23. Menaka 57/F 6/12 6/18 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 94.1 94.4 102.7 103 
24. Ganesh kumar 27/M 6/6 6/9 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
25. Eswaraiya  55/M  6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
26. Dinesh 21/M 6/9 6/9 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
27. Maruthai  50/M 6/9 6/6 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
28. Narayanan 28/M 6/18 6/12 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
29. Mohana 47/F 6/18 6/18 77.1 77.4 65.7 66.0 64.1 63.4 64.1 64.4 52.7 53 51.1 50.4 104.1 104.4 92.7 93 91.1 90.4 
30. Valli 50/F 6/36 6/12 78.4 77.1 68.4 67.1 78.4 77.1 65.4 64.1 55.4 54.1 65.4 64.1 105.4 104.1 95.4 94.1 105.4 104.1 
31. Anbu  49/M 6/12 6/12 75.7 77.4 64.1 66.0 62.4 63.4 62.7 64.4 51.1 53 49.4 50.4 102.7 104.4 91.1 93 89.4 90.4 
32. Mahalingam  43/M 6/24 6/18 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
33. Ganesh  55/M 6/24 6/24 78.4 77.1 68.4 67.1 78.4 77.1 65.4 64.1 55.4 54.1 65.4 64.1 105.4 104.1 95.4 94.1 105.4 104.1 
34. Ramesh 30/M 6/9 6/12 75.7 77.1 63.4 65.7 62.9 64.1 62.7 64.1 50.4 52.7 49.9 51.1 102.7 104.1 90.4 92.7 89.9 91.1 
S.N
O 
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/SEX 
VISION OPP (mmHg) DOPP  (mmHg) SOPP (mmHg) 
T1 T2 T3 T1 T2 T3 T1 T2 T3 
RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE 
35. Amelarpara mary 57/F 6/12 6/9 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
36. Chandrasekar 25/M 6/9 6/9 82 82.3 77.1 78.7 77.1 78.7 65.4 65.7 64.1 65.7 64.1 65.7 115.4 115.7 104.1 105.7 104.1 105.7 
37. Mala 30/F 6/6 6/6 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
38 Periyandi 62/M 6/9 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
39 Chalapathy 40/M 6/36 6/24 77.1 77.4 65.7 66.0 64.1 63.4 64.1 64.4 52.7 53 51.1 50.4 104.1 104.4 92.7 93 91.1 90.4 
40. Sankaraselvi 40/F 6/24 6/24 89.3 87.7 77.7 76 76 74.7 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
41.  Padmavathi 42/F 6/12 6/12 78.4 77.1 68.4 67.1 78.4 77.1 65.4 64.1 55.4 54.1 65.4 64.1 105.4 104.1 95.4 94.1 105.4 104.1 
42. Banu  48/F 6/12 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
43. Murugan 46/M 6/12 6/12 75.7 77.4 64.1 66.0 62.4 63.4 62.7 64.4 51.1 53 49.4 50.4 102.7 104.4 91.1 93 89.4 90.4 
44. MohamedImbran 57/M 6/24 6/24 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
45. George joshva  39/M 6/12 6/12 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
46 Savitha 30/F 6/6 6/6 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 94.1 94.4 102.7 103 
47. Narayanan 46/M 6/6 6/6 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
48. Latha 30/F 6/12 6/12 78.4 77.1 68.4 67.1 78.4 77.1 65.4 64.1 55.4 54.1 65.4 64.1 105.4 104.1 95.4 94.1 105.4 104.1 
49. Murugan  45/M 6/36 6/24 77.1 77.4 65.7 66.0 64.1 63.4 64.1 64.4 52.7 53 51.1 50.4 104.1 104.4 92.7 93 91.1 90.4 
50. Ramesh  28/M 6/24 6/24 89.3 87.7 77.7 76 76 74.7 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
51. Krishnamoorthy 52/M 6/12 6/12 75.7 77.4 64.1 66.0 62.4 63.4 62.7 64.4 51.1 53 49.4 50.4 102.7 104.4 91.1 93 89.4 90.4 
52. Shylaja 30/F 6/6 6/6 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 94.1 94.4 102.7 103 
53. Govindasamy  40/M 6/12 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
54. Babitha dass  49/F 6/12 6/12 75.7 77.4 64.1 66.0 62.4 63.4 62.7 64.4 51.1 53 49.4 50.4 102.7 104.4 91.1 93 89.4 90.4 
55. Dhandapani  47/M 6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
56. Paramasivan  28/M 6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
57. Punitha  50/F 6/24 6/24 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 104.1 104.4 102.7 103 
58. Rubashree 21/F 6/9 6/9 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
59. Athish   30/M 6/12 6/12 75.7 77.1 63.4 65.7 62.9 64.1 62.7 64.1 50.4 52.7 49.9 51.1 102.7 104.1 90.4 92.7 89.9 91.1 
60. Varalakshmi 42/F 6/24 6/24 89.3 87.7 77.7 76 76 74.7 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
61. Vasuki 48/F 6/24 6/24 82 82.3 77.1 78.7 77.1 78.7 65.4 65.7 64.1 65.7 64.1 65.7 115.4 115.7 104.1 105.7 104.1 105.7 
62. Gomathi 43/F 6/36 6/18 87.7 89.3 76 77.7 74.7 76 71.1 72.7 59.4 61.1 58.1 59.4 121.1 122.7 109.4 111.1 108.1 109.4 
63. Ramu 32/M 6/12 6/12 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
64. Kumar  47/M 6/6 6/6 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
65. Manogaran  57/M 6/9 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
66. Manikkam  57/M  6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
67. Saidhani   42/F 6/24 6/24 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 94.1 94.4 102.7 103 
68. Babarao 49/M 6/12 6/12 74.1 75.7 63.4 64.1 59.9 59.9 61.1 62.7 50.4 51.1 49.9 49.9 101.1 102.7 90.4 91.1 79.9 79.9 
69. Prakasam  50/m 6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
70. Menaka   45/F 6/9 6/9 69.7 69.7 63.4 64.1 62.4 59.9 52.7 52.7 50.4 51.1 49.4 49.9 102.7 102.7 90.4 91.1 89.4 89.9 
71. Thenmozhi 50/F 6/24 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
72. Vasanthi  45/F 6/9 6/9 77.1 77.4 65.7 66.0 64.1 63.4 64.1 64.4 52.7 53 51.1 50.4 104.1 104.4 92.7 93 91.1 90.4 
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73. Selvi  40/F  6/12 6/12 74.1 75.7 63.4 64.1 59.9 59.9 61.1 62.7 50.4 51.1 49.9 49.9 101.1 102.7 90.4 91.1 79.9 79.9 
74. Kannan  31/M  6/12 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
75. Velu  46/M  6/12 6/12 75.7 77.4 64.1 66.0 62.4 63.4 62.7 64.4 51.1 53 49.4 50.4 102.7 104.4 91.1 93 89.4 90.4 
76. Annammal  52/F 6/18 6/12 89.3 87.7 77.7 76 72.4 71.1 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
77. Jayalakshmi 55/F 6/9 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
78. Williams Durai  38/M  6/24 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
79. Vijaya  40/F 6/18 6/12 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
80. Ramesh  40/M 6/9 6/9 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
81. Forook  50/M 6/18 6/18 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
82. Shenbagavalli  60/F  6/24 6/12 78.4 77.1 68.4 67.1 78.4 77.1 65.4 64.1 55.4 54.1 65.4 64.1 105.4 104.1 105.4 104.1 105.4 104.1 
83. Elizabeth  53/F 6/12 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
84. Jothi 40/F 6/12 6/18 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 104.1 104.4 102.7 103 
85. Joseph 50/M 6/6 6/9 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
86. Parveen 32/F 6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 64.1 65.7 64.1 65.7 115.4 115.7 104.1 105.7 104.1 105.7 
87. Mohd. roshan  56/M 6/9 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
88. Balaraman  48/M 6/9 6/9 77.1 77.4 65.7 66.0 64.1 63.4 64.1 64.4 52.7 53 51.1 50.4 104.1 104.4 92.7 93 91.1 90.4 
89. Lakshmiammal  53/F 6/36 6/18 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
90. Punitha 50/F 6/12 6/12 75.7 77.1 63.4 65.7 62.9 64.1 62.7 64.1 50.4 52.7 49.9 51.1 102.7 104.1 90.4 92.7 89.9 91.1 
91. Kanagaraj 45/M  6/24 6/36 78.4 78.7 67.1 67.4 65.7 66 65.4 65.7 54.1 54.4 52.7 53 105.4 105.7 94.1 94.4 92.7 93 
92. Shankar 42/M 6/24 6/9 89.3 87.7 77.7 76 62.4 61.1 72.7 71.1 61.1 59.4 49.4 48.1 122.7 121.1 111.1 109.4 89.4 88.1 
93. Chindhanaiselvi 56/F 6/24 6/36 82 82.3 77.1 78.7 77.1 78.7 65.4 65.7 64.1 65.7 64.1 65.7 115.4 115.7 104.1 105.7 104.1 105.7 
94. Ramu 40/M 6/9 6/12 75.7 75.7 64.1 63.4 62.4 62.9 62.7 62.7 51.1 50.4 49.4 49.9 102.7 102.7 91.1 90.4 89.4 89.9 
95. Bhavani 46/F 6/18 6/12 89.3 87.7 77.7 76 72.4 71.1 72.7 71.1 61.1 59.4 59.4 58.1 122.7 121.1 111.1 109.4 109.4 108.1 
96. Jaikumar  53/M 6/9 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
97. Marimuthu  57/M 6/24 6/18 74.1 74.1 62.4 61.1 61.1 61.1 61.1 61.1 49.4 48.1 48.1 48.1 101.1 101.1 89.4 88.1 88.1 88.1 
98. Gajalakshmi 45/F 6/18 6/12 99.3 97.7 87.7 87.7 76 76 82.7 81.1 71.1 71.1 59.4 59.4 132.7 131.1 121.1 121.1 109.4 109.4 
99. Malarkodi 51/F 6/24 6/24 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 104.1 104.4 102.7 103 
100. Sudha 40/F 6/12 6/18 78.4 78.7 67.1 67.4 75.9 76 65.4 65.7 54.1 54.4 62.7 63.0 105.4 105.7 101.1 102.4 102.7 103 
 
FOLLOW- UP CHART 
S.
N
O 
NAME 
IOP (mmHg) MOPP (mm Hg) DOPP (mmHg) SOPP (mmHg) 
GLAUCOMATOUS OPTIC NERVE HEAD 
CHANGES 
GLAUCOMATOUS DEFECTS IN PERIMETRY 
RE LE RE LE RE LE RE LE RE LE RE LE 
V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 
1 Sasikumar  18 20 20 18 18 20 50.2 48.6 48.6 50.2 50.2 48.6 62 60 60 62 62 60 102 104 104 102 102 104 NO NO NO NO NO NO NO NO NO NO NO NO 
2 SanthoshKumr 16  18  20  18  16  20  54  52.4 63 52.4 54 63 64 62 60 62 64 60 114 112 110 112 114 110 NO NO NO NO NO NO NO NO NO NO NO NO 
3 Vinothraj  20 18 18 18 20 20 64.4 65.3 65.3 65.3 64.4 64.4 80 82 82 82 80 80 130 132 132 132 180 180 NO NO NO NO NO NO NO NO NO NO NO NO 
4 Samuvel Raja  16  18  20  16  18  20  51.3  50  49 51.3 50 49 74 72 70 74 72 70 124 122 120 124 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
5 Gnanaprakasn 18  20  20  18  18  20  64  62 62 64 64 62 82 80 80 82 82 80 122 120 120 122 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
6 Chinnapaiyan 16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
7 Kotti 16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO NO NO NO NO NO NO NO NO NO NO 
8 Silambarasan 16 20 18 16 20 18 51.3 64.4 65.3 51.3 64.4 65.3 74 80 82 74 80 82 124 130 132 124 130 132 NO NO NO NO NO NO NO NO NO NO NO NO 
9 Sekar  18  20  20  18  20  20  52.4  63  62 64 63 62 62 60 80 82 80 60 112 110 120 122 120 110 NO NO NO NO NO NO NO NO NO NO NO NO 
10 Lakshmanan 18 20 20 18 18 20 50.2 48.6 48.6 50.2 50.2 48.6 62 60 60 62 62 60 102 104 104 102 102 104 NO NO YES NO NO YES NO YES YES NO YES YES 
11 Savarimuthu 16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
12 Kannnan  18 20 20 18 18 20 50.2 48.6 48.6 50.2 50.2 48.6 62 60 60 62 62 60 102 104 104 102 102 104 NO NO NO NO NO NO NO NO NO NO NO NO 
13 Ganesh kumar 16  18  20  18  16  20  54  52.4 63 52.4 54 63 64 62 60 62 64 60 114 112 110 112 114 110 NO NO NO NO NO NO NO NO NO NO NO NO 
14 Eswaraiya  16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO YES NO NO YES NO YES YES NO YES YES 
15 Dinesh 16  16  LF  16  16  LF  54 54 LF 54 54 LF 64  62  LF  64 62 LF 114 102 LF 114 102 LF NO NO LF NO NO LF NO NO LF NO NO LF 
16 Mohana 16 20 18 16 20 18 51.3 64.4 65.3 51.3 64.4 65.3 74 80 82 74 80 82 124 130 132 124 130 132 NO NO NO NO NO NO NO NO NO NO NO NO 
17 Anbu  18  20  20  18  20  20  52.4  63  62 64 63 62 62 60 80 82 80 60 112 110 120 122 120 110 NO NO NO NO NO NO NO NO NO NO NO NO 
18 Mahalingam  18  20  20  18  18  20  64  62 62 64 64 62 82 80 80 82 82 80 122 120 120 122 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
19 Ramesh 16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
20 Mala 16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO NO NO NO NO NO NO NO NO NO NO 
21 Periyandi 16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO NO NO NO NO NO NO NO NO NO NO 
22 Chalapathy 18 20 20 18 18 20 50.2 48.6 48.6 50.2 50.2 48.6 62 60 60 62 62 60 102 104 104 102 102 104 NO NO NO NO NO NO NO NO NO NO NO NO 
23 Banu  16  18  LF  18  16  LF  54 52.4 LF 52.4 54 LF 64  62  LF  62 64 LF 114 112 LF 112 114 LF NO YES LF NO YES LF NO YES LF NO YES LF 
24 Murugan 20 18 18 18 20 20 64.4 65.3 65.3 65.3 64.4 64.4 80 82 82 82 80 80 130 132 132 132 180 180 NO NO NO NO NO NO NO NO NO NO NO NO 
25 George joshva 16  18  20  16  18  20  51.3  50  49 51.3 50 49 74 72 70 74 72 70 124 122 120 124 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
26 Narayanan 18  20  LF  18  18  LF  64 62 LF 64 64 LF 82  80  LF  82 82 LF 122 120 LF 122 122 LF NO NO LF NO NO LF NO NO LF NO NO LF 
27 Murugan 16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
28 Krishnamoorti 16  20  LF  16  20  LF  51.3 64.4 LF 51.3 64.4 LF 74  80  LF  74 80 LF 124 130 LF 124 130 LF NO NO LF NO NO LF NO NO LF NO NO LF 
29 Govindasamy  18  20  LF  18  20  LF  52.4 63 LF 64 63 LF 62  60  LF  82 80 LF 112 110 LF 122 120 LF NO NO LF NO NO LF NO NO LF NO NO LF 
30 Babitha dass  18  20  LF  18  18  LF  50.2 48.6 LF 50.2 50.2 LF 62  60  LF  62 62 LF 102 104 LF 102 102 LF NO NO LF NO NO LF NO NO LF NO NO LF 
31 Dhandapani  16  18  20  18  16  20  54  52.4 63 52.4 54 63 64 62 60 62 64 60 114 112 110 112 114 110 NO NO NO NO NO NO NO NO NO NO NO NO 
32 Paramasivan  16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO NO NO NO NO NO NO NO NO NO NO 
33 Athish  18  20  20  18  18  20  64  62 62 64 64 62 82 80 80 82 82 80 122 120 120 122 122 120 NO YES YES NO YES YES NO YES YES NO YES YES 
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V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 V1 V2 V3 
34 Ramu 16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
35 Kumar  16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO NO NO NO NO NO NO NO NO NO NO 
36 Manogaran  18 LF LF 18 LF LF 50.2 LF LF 50.2 LF LF 62 LF LF 62 LF LF 102 LF LF 102 LF LF NO LF LFF NO LF LF NO LF LF NO LF LF 
37 Manikkam  16  18  20  18  16  20  54  52.4 63 52.4 54 63 64 62 60 62 64 60 114 112 110 112 114 110 NO NO NO NO NO NO NO NO NO NO NO NO 
38 Ramesh 20 18 18 18 20 20 64.4 65.3 65.3 65.3 64.4 64.4 80 82 82 82 80 80 130 132 132 132 180 180 NO YES YES NO YES YES NO YES YES NO YES YES 
39 Prakasam  16  18  20  16  18  20  51.3  50  49 51.3 50 49 74 72 70 74 72 70 124 122 120 124 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
40 Menaka   18  20  LF  18  18  LF  64 62 LF 64 64 LF 82  80  LF  82 82 LF 122 120 LF 122 122 LF NO NO LF NO NO LF NO NO LF NO NO LF 
41 Thenmozhi 16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
42 Vasanthi  18  20  20  18  20  20  52.4  63  62 64 63 62 62 60 80 82 80 60 112 110 120 122 120 110 NO NO NO NO NO NO NO NO NO NO NO NO 
43 Selvi  18  20  20  18  18  20  64  62 62 64 64 62 82 80 80 82 82 80 122 120 120 122 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
44 Kannan  16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
45 Velu  16  16  LF  16  18  LF  54 54 LF 54 52.4 LF 64  64  LF  64 62 LF 114 114 LF 114 112 LF NO NO LF NO NO LF NO NO LF NO NO LF 
46 Williams Durai 18 20 20 18 18 20 50.2 48.6 48.6 50.2 50.2 48.6 62 60 60 62 62 60 102 104 104 102 102 104 NO NO NO NO NO NO NO NO NO NO NO NO 
47 Marimuthu   16  18  LF  18  16  LF  54 52.4 LF 52.4 54 LF 64  62  LF  62 64 LF 114 112 LF 112 114 LF NO YES LF NO YES LF NO YES LF NO YES LF 
48 Forook  16  16  LF  16  16  LF  54 54 LF 54 54 LF 64  62  LF  64 62 LF 114 102 LF 114 102 LF NO NO LF NO NO LF NO NO LF NO NO LF 
49 Jayalakshmi 16 20 18 16 20 18 51.3 64.4 65.3 51.3 64.4 65.3 74 80 82 74 80 82 124 130 132 124 130 132 NO NO NO NO NO NO NO NO NO NO NO NO 
50 Shankar 16  16  18  16  18  20  54  54 52.4 54 52.4 63 64 64 62 64 62 60 114 114 112 114 112 110 NO NO NO NO NO NO NO NO NO NO NO NO 
51 Moh.d roshan  18  20  LF  18  18  LF  50.2 48.6 LF 50.2 50.2 LF 62  60  LF  62 62 LF 102 104 LF 102 102 LF NO NO LF NO NO LF NO NO LF NO NO LF 
52 Balaraman  16  18  20  18  16  20  54  52.4 63 52.4 54 63 64 62 60 62 64 60 114 112 110 112 114 110 NO NO NO NO NO NO NO NO NO NO NO NO 
53 Punitha 20 18 18 18 20 20 64.4 65.3 65.3 65.3 64.4 64.4 80 82 82 82 80 80 130 132 132 132 180 180 NO NO NO NO NO NO NO NO NO NO NO NO 
54 Kanagaraj 16  18  20  16  18  20  51.3  50  49 51.3 50 49 74 72 70 74 72 70 124 122 120 124 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
55 Ramu 18  20  20  18  18  20  64  62 62 64 64 62 82 80 80 82 82 80 122 120 120 122 122 120 NO NO NO NO NO NO NO NO NO NO NO NO 
56 Joseph  16  16  18  16  16  18  54  54 50.2 54 54 50.2 64 62 62 64 62 62 114 102 102 114 102 102 NO NO NO NO NO NO NO NO NO NO NO NO 
57 Jaikumar  18  20  20  18  20  20  52.4  63  62 64 63 62 62 60 80 82 80 60 112 110 120 122 120 110 NO NO NO NO NO NO NO NO NO NO NO NO 
58 Babarao  18 20 20 18 18 20 50.2 48.6 48.6 50.2 50.2 48.6 62 60 60 62 62 60 102 104 104 102 102 104 NO NO NO NO NO NO NO NO NO NO NO NO 
  
